USA) lollohing AITE in Gr 1 and o n thc day o l evaluation ; I I 1 ~n n n t l l o f ngc I n Gr 2. l'lic 2 groups wcrc coniparablc l o r b i r t h \vcight, gcst,~l~unn.ll .igr a n d sex ratio. The severity o f GER assesscd b y ocsoph.igcal p l l \\,as also sirn11.u i n tlic 2 groups : acidity indes ( 9' 0 o f tlic recording pcrlod \ v~t l i p l l bclow 4 ) was rcspectivcly o f 10,6% + 3,Sh i n g r 1 ;uid 13,O'fi + S.OCYo i n gr 2 .
The number o f reflux per h o u r was 11 + 6 a n d 16 + S.lJ1.tsmL~ B c n d o r p l i l n levcls was 84.5 + 8 0 p g / m l in gr 1 (15-312 . median 47 pglrnl) a n d 25.9 + 31 p g / m l i n gr 2 (5-91 p g i m l . nicdlan 14 p g / m l ) p < 0.01 . I n group 1 .4 h.ihics h a d lc\'els abovc 125 p g / m l (normal mean plasma level :29 p g l m l ) .
l'licsc data suggcst 1) GER can b e associated to a n incrcascd p r o d u c t i o n o f Uc1.1 cndorphins probably in rcsponse to the oesoplingc.~l insult ~n d u c e d h y acidlty. Beta-endorphin may induce r e s p i r a t o r y depression and bradycardia. Elevated hypoxanthine (BX) l e v e l i n corpus v i t r e u m humor (CVH) i n d i c a t e s hypoxia before death. We measured beta-endorphin i m u n o r e a c t i v i t y (BEI) i n CSF and HX i n CVll I n SIDS v i c t i m s (11. 27) and 111 c o n t r o l i n f a n t s (11.12).
I n a p i l o t study we measured DEI i n CSF I n p l g l e t s where t h c l a r y n x r e f l e x was induced by amnonlum gas (n.4). DEI i n CSF was a l s o measured a f t e r b r a i n hypoxia i n pig1e:s (17.6).
The BE1 l e v e l s i n CSF d i v i d e d the SIDS v i c t i m s i n t o two subpopulations: one h a l f w i t h undetectable l e v e l ~4 . 3 fmol/ml CSF, and the o t h e r h a l f w i t h h i g h l e v e l 247 fmol/ml CSF (range 160-400). A l l t h c SIDS v l c t l m s had elevated l e v e l s o f HX I n CVH 209 mikromol/l (range 53-419) compared w i t h the c o n t r o l s t h a t d l e d a sudden death (accidental, c a r d l a l o r z t r a n g l e d ) , whlch had 54 mlkromol/l (range 0-188). I n the subpopulatlon o f SIDS v l c t i m s w l t h elevated BE1 I n CSF, we found a p o s i t i v e c o r r e l a t i o n between BE1 I n CSF and I1X l e v e l s I n CirH ~~0 . 9 2 (pt0.001). I n the c o n t r o l i n f a n t s no c o r r e l a t i o n between 821 I n CSF and IIX i n CYH was found. I n p i g l e t s where the l a r y n x r e f l e x was c x c l t e d , wc found increased l c v c l s of DEI I n CSF h h l c h c o r r e l a t e d w l t h t h e d u r a t i o n o f the apneas r=O.C4 (p-0.16). I n t h c c o n t r o l p i g l e t s undetectable l e v e l s of DEI i n CSF was found Conclusion: I n SIDS v i c t l m s w l t h c l e v a t c d l e v e l s o f DEI i n CSF, the DEI c o r r e l a t e d w l t h IiX i n CVH. The l a r y n x r e f l e x lnduced apneas, lnduced BE1 increase I n CSF i n p l q l e t s . Cllildren's University Hospital. Munster. *University Laboratories. Regensburg. FAG rH-€PO has been studied as a new treatment regime for the anemia of prematurity i n t w o multicentre studies In order to avoid red cell transfusion with its potential hazards. Methods: We randomly assigned 29 premature infants to 2 treatment schedules with rH-EPO or none, Infants in treatment group 1 I n = 8, mean BW 1 4 3 6 + 1-3 5 7 g, mean GA 3 1 w l received 7 0 IU rH-EPOlkgBWlw upto day 2 5 of life by subcutaneous injection Into thigh, those in treatment group 2 I n = 6, mean DW 1 2 8 4 + / -I 4 8 9. mean GA 31 w l 750 UllkgBWlw upto day 4 2 of lifo. those I n the control oroup I n = 15, mean BW 1327 + I -3 1 6 0. moan GA 3 0 w ) rccoived no treatment. All infenls received supplemental iron orally from day 1 4 of life. &&& Moan number of pocked red cell transfusions per patient during the stlldy poriod wero 1.4 units (controlsl. 1.6 units (70 IU groupl and 0.1 7 tlnils I 7 5 0 IU o r o u p l Meon rotlculocyte counts were at day 3 of lile were 10.1 + I -5 % lconlrolsl. 8.8 + 1-4.4 % I 7 5 IU group) and 8.2 + I . 6.5 % 1750 IU groupl. I n both ill0 control ond tho 7 5 IU group mean retlculocytes count decreased during ohscrvation time to mean values between 3 end 4 %, while i t increased in the 750 IU group to a highest value of 10.6 +I-2.3 % in week 3 and stayed at a high level of 7 to 8 % until weok 5. Mean absolute normocyte count fell in a logarithmic manner but values wero higher in both treetment groups. The biggest difference was observod in weok 4 with a mean of 1 8 0 normocytes in the.750 IU group. 7 5 ill the 7 5 IU oroup and only 1G in the control group. Concluwon: Low dose rH-EPO showed no sufficient effect for the treatment of anemia of prematurity. High dose rH-EPO prevents the need for transfusion In preterm infants, stimulates endonenous generation of normovolaemic hypochrome erythrocytes and does not stinlulate other cell lines than tho red cell lino. 
MEASURINO BODY FAT IN INFANCY: ANTHROPOMETRY VERSUS TOTAL BODY

u r p o s e o f t h i s s t u d y was t o a s s e s s t h e e x t e n t o f l n v o l m e n t o f r a s o n c o q e n c s i n o s t c o s a r c o m a . STUDY DESIGN:
Tumor s a m p l e s f r o m a s e r i e s of 5 3 p e d i a t r i c p a t i e n t s 
